Delivery of Nucleic Acid Therapeutics III: Biology, Engineering and Development
Preliminary Program
Keynote Speakers
Anastasia Khvorova
University of Massachusetts, USA
Frank Bennett
Ionis Pharmaceuticals, USA
Invited Speakers
Isabel Aznarez, Stoke, USA
Jake Brenner, U Penn, USA
Mike Byrne, WaVe Therapeutics, USA
David Corey, UT Southwestern Medical Center, USA
Cecilia Cotta-Ramusino, Tessera, USA
Masad Dahma, McGill University, Canada
Yogev Debbi, Mana Bio, Isreal
Lavi Erisson, Gensaic, USA
Ian Huggins, Ionis, USA
Adrian Krainer, Cold Spring Harbor Laboratory, USA
Art Krieg, Zola Therapeutics
Matt Levy, Creyon
Michael J. Mitchell, U Penn, USA
Kalina Paunovska, Nava Therapeutics
Bill Querbes, Aera Therapeutics, USA
Sahay Guarav, Oregon Health & Sciences University, USA
Mark Schlegel, Alnylam Pharmaceuticals, USA
Anders Wittrup, Lund University, Sweden
Marino Zerial, Human Technopole , Milano, Italy
Tracy Zimmerman, City Therapeutics, USA
Call for Abstracts
Abstracts (one page maximum) that include specific results and conclusions to allow a
scientific assessment of the proposed oral presentation are invited. Please prepare
your abstract according to this template: docx or doc.
Abstracts must be submitted electronically using the template provided at THIS LINK.
Oral abstract submission extended deadline: March 15, 2026
Poster abstract submission extended deadline: March 15, 2026
Abstracts of all presentations will be made available to conference participants prior to
the start of the conference.
Note: Only a limited number of oral presentation slots are available and thus all submissions for oral sessions will be considered for both oral and poster presentation.